Bioforce Nanosciences Holdings Inc. Financials
BFNH
All currency values in $ millions unless otherwise noted
Scroll
| Income Statement | TTM | DEC 2025 | DEC 2024 | DEC 2023 | DEC 2022 | DEC 2021 ~1.8:1 split |
|---|---|---|---|---|---|---|
| Revenues | ||||||
| Revenue | $0 | – | – | – | – | – |
| Cost of Revenue | $0 | – | – | – | – | – |
| Gross Profit | $0 | – | – | – | – | – |
| General & Administrative | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $0 | $0 | $0 | $0 | $0 | $1 |
| Operating Income | -$0 | – | – | – | – | – |
| EBT (Earnings Before Tax) | -$0 | -$0 | -$0 | – | – | – |
| Net Income | ||||||
| Net Income | -$0 | -$1 | -$0 | -$0 | -$0 | -$1 |
| Per Share Data | ||||||
| Revenue Per Share | $0.00 | – | – | – | – | – |
| EPS (Basic) | -$0.00 | -$0.04 | -$0.02 | -$0.02 | -$0.02 | -$0.02 |
| EPS (Diluted) | -$0.00 | -$0.04 | -$0.02 | -$0.02 | -$0.02 | -$0.02 |
| Weighted Avg Shares (Basic) | 15.3M | 33.2M | 29.3M | 29.3M | 29.3M | 29.3M |
| Weighted Avg Shares (Diluted) | 15.3M | 33.2M | 29.3M | 29.3M | 29.3M | 29.3M |
| Shares Outstanding | 15.3M | 33.2M | 29.3M | 29.3M | 29.3M | 29.3M |
Bioforce Nanosciences Holdings (BFNH) financials: revenue, profit and margins
Bioforce Nanosciences Holdings (BFNH) generated about n/a in revenue and -$323,207.00 in net income over the trailing twelve months, growing at roughly 98.7% a year. Figures are from SEC filings; this is analysis, not investment advice.
Frequently asked
Is Bioforce Nanosciences Holdings profitable?+
Bioforce Nanosciences Holdings reported about -$323,207.00 in net loss over the trailing twelve months. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.
How fast is Bioforce Nanosciences Holdings growing?+
Bioforce Nanosciences Holdings's revenue has compounded at roughly 98.7% a year over the past five years. Growth only creates value when it is profitable and cash-generative, so read this rate alongside BFNH's margins and free cash flow. This is analysis from SEC filings, not investment advice.
SourceFinancial statements computed from the 10-Q filed 9 Nov 2026, covering the period ending 31 Dec 2026, as reported to the SEC. Data last refreshed 12 Nov 2026. How this is calculated.
Fiscal year ends Dec.
Peers
Laboratory Analytical Instruments · Pick stocks to compare with BFNH
Spot a number that looks wrong? Check it in BFNH's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing BFNH
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.